HOME ⤏ WHO WE ARE ⤏ CORDENPHARMA
Full-Service CDMO Partner
- Formed in 2006 as the pharmaceutical brand of ICIG
- Full-Service CDMO organized in 4 distinctive platforms with specialized characteristics
- Marketing & Sales provided by CordenPharma International for separately managed operating companies (legal and financial independence)
- 8 GMP production facilities in Europe and the United States
- € 390 million total sales
- 1,530 employees
Key Technologies
Drug Substance
Small Molecule Intermediates & APIs
Excipients
Peptides
Lipids
Carbohydrates
Conjugates
Highly Potent API’s
Oncology API’s
Sterile API’s
Excipients
Peptides
Lipids
Carbohydrates
Conjugates
Highly Potent API’s
Oncology API’s
Sterile API’s
Key Technologies
Drug Product
Injectables (Vials, Ampoules, Pre-filled Syringes)
Sterile Emulsion Technology
Oral Solid Dosage Forms
Coated & Uncoated Tablets
Hard Gelatine Capsules
Sterile Liquid & Lyophilisation (Vials & Ampules)
Primary & Secondary Packaging
Blister & Bottle Packaging
Serialisation & 2D Data Matrix Coding
Clinical Trial Services
Sterile Emulsion Technology
Oral Solid Dosage Forms
Coated & Uncoated Tablets
Hard Gelatine Capsules
Sterile Liquid & Lyophilisation (Vials & Ampules)
Primary & Secondary Packaging
Blister & Bottle Packaging
Serialisation & 2D Data Matrix Coding
Clinical Trial Services
visit the website
ICIG PLATFORMS
OUR SITES
› Homepage
› Our Approach
› Our Investments
› News
› Sitemap
› Contact
ABOUT
› Who we are
› WeylChem
› Catexel
› Vynova
› Benvic
› HCS Group
› Stockhausen
› Enterprises
ICI HOLDING SE
GERMANY
Goetheplatz 5-7
D-60313 Frankfurt
Phone: +49 (69) 506 999-0
Fax: +49 (69) 506 999-11
E-Mail: info @ ic-investors.com
Web: www.ic-investors.com
